Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Knutson

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
International Journal of Pharmaceutics|January 19, 2023
High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: Physicochemical, structural and pharmacokinetic performancesJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
ACS Chemical Neuroscience|August 14, 2020
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure EffectsDaniel E Knutson, Jodi L Smith, Xingjie Ping, et al.
British Journal of Pharmacology|March 9, 2018
Cerebellar α<sub>6</sub> -subunit-containing GABA<sub>A</sub> receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disordersLih-Chu Chiou, Hsin-Jung Lee, Margot Ernst, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|March 1, 2021
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligandsKamal P Pandey, Zubair Ahmed Khan, Lalit K Golani, et al.
Molecular Neuropsychiatry|June 14, 2019
Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive ProfilesThomas D Prevot, Guanguan Li, Aleksandra Vidojevic, et al.
Journal of Medicinal Chemistry|February 27, 2018
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) α6 Subtype with Improved Metabolic Stability and Enhanced BioavailabilityDaniel E Knutson, Revathi Kodali, Branka Divović, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
International Journal of Pharmaceutics|January 19, 2023
High amount of lecithin facilitates oral delivery of a poorly soluble pyrazoloquinolinone ligand formulated in lipid nanoparticles: Physicochemical, structural and pharmacokinetic performancesJelena R Mitrović, Branka Divović-Matović, Daniel E Knutson, et al.
ACS Chemical Neuroscience|August 14, 2020
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure EffectsDaniel E Knutson, Jodi L Smith, Xingjie Ping, et al.
British Journal of Pharmacology|March 9, 2018
Cerebellar α<sub>6</sub> -subunit-containing GABA<sub>A</sub> receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disordersLih-Chu Chiou, Hsin-Jung Lee, Margot Ernst, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|March 1, 2021
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligandsKamal P Pandey, Zubair Ahmed Khan, Lalit K Golani, et al.
Molecular Neuropsychiatry|June 14, 2019
Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive ProfilesThomas D Prevot, Guanguan Li, Aleksandra Vidojevic, et al.
Journal of Medicinal Chemistry|February 27, 2018
Design and Synthesis of Novel Deuterated Ligands Functionally Selective for the γ-Aminobutyric Acid Type A Receptor (GABA<sub>A</sub>R) α6 Subtype with Improved Metabolic Stability and Enhanced BioavailabilityDaniel E Knutson, Revathi Kodali, Branka Divović, et al.
Pageof 3